Sickle-cell disease predominates in Africa. 镰状细胞病主要见于非洲。
Poor blood oxygen levels and blood vessel blockages in people with sickle-cell disease can lead to chronic acute pain syndromes, severe bacterial infections, and necrosis ( tissue death). 镰状细胞病患者血液含氧量低并且发生血管堵塞,可导致出现慢性和急性疼痛综合症、重度细菌感染和坏疽(组织坏死)。
Sickle-cell disease is characterized by a modification in the shape of the red blood cell from a smooth, donut-shape into a crescent or half moon shape. 镰状细胞病的特征是红血球形状发生突变,由平滑的圆圈形状改变为新月形或半月形。
This has been done successfully in mice with sickle-cell disease, but will not be possible for some years in people. 在患有镰刀形细胞症的实验鼠身上此法已获成功。但是,在未来几年,此法尚无法在人类患者身上实施。
One option in future may be to create stem cells from a patient's own tissue, then return these after using gene therapy to correct the genetic mutation that causes sickle-cell disease. 未来一个选择是从患者的组织培养干细胞、经基因疗法纠正导致镰刀形细胞症的遗传变异后再移植给患者本身。
Likewise, in people with a genetic disorder such as sickle cell anemia, the new blood system would not have the sickle-cell mutation, eliminating the cause of disease. 同样的,对于遗传疾病(如镰状细胞性贫血)患者,新造血系统不再有镰状红细胞变异,因此消除了该疾病的病因。
Sickle-cell disease and severe forms of thalassaemia ( thalassaemia major) can occur only when both parents are carriers of trait genes for the particular condition. 只有当父母双方都携带特定疾病的特征基因时,才有可能发生镰状细胞病和严重的地中海贫血(重型地中海贫血)。